ROBINSON JAMES GEORGE purchased 0.3% of their position (9K shares) of NYMOX PHARMACEUTICAL CORP on the open market
Open‑market purchase worth $14.0K — a small addition. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 6/28/2019ACC: 0001651844-19-000017
Director
Since Oct 2018
+9K
Net shares
Net buyer
$14.0K
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
9K acquired
Non-Derivative Transactions5
Common Stock
Direct
Shares
+1.73K
Price / share
$1.56
Trade value
$2.70K
% of position
0.1%
6/27/2019
3.45M→3.45M
Common Stock
Direct
Shares
+32.00
Price / share
$1.56
Trade value
$49.86
% of position
0.0%
6/27/2019
3.45M→3.45M
Common Stock
Direct
Shares
+6.24K
Price / share
$1.56
Trade value
$9.73K
% of position
0.2%
6/27/2019
3.45M→3.46M
Common Stock
Direct
Shares
+473.00
Price / share
$1.55
Trade value
$734.10
% of position
0.0%
6/27/2019
3.46M→3.46M
Common Stock
Direct
Shares
+527.00
Price / share
$1.54
Trade value
$812.63
% of position
0.0%
6/27/2019
3.46M→3.46M
Total
Net shares
+9K
Net value
$14.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/27/2019 | P · Purchase | +1.73K | $1.56 | $2.70K | 0.1% | 3.45M | 3.45M |
| Common Stock Direct | 6/27/2019 | P · Purchase | +32.00 | $1.56 | $49.86 | 0.0% | 3.45M | 3.45M |
| Common Stock Direct | 6/27/2019 | P · Purchase | +6.24K | $1.56 | $9.73K | 0.2% | 3.45M | 3.46M |
| Common Stock Direct | 6/27/2019 | P · Purchase | +473.00 | $1.55 | $734.10 | 0.0% | 3.46M | 3.46M |
| Common Stock Direct | 6/27/2019 | P · Purchase | +527.00 | $1.54 | $812.63 | 0.0% | 3.46M | 3.46M |
| Total | +9K | $14.02K | ||||||
Derivative Transactions0
No derivative transactions reported